Abstract
The recently published 2 reports of the International Harmonization Project (IHP) in Lymphoma recommended the routine use of 18F-FDG PET for posttherapy assessment of patients with Hodgkin's disease (HD) and diffuse large B-cell lymphoma, the most common and potentially curable form of aggressive
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
